Noncoding RNAs in tumorigenesis and tumor therapy

被引:10
|
作者
Zhu, Pingping [1 ,2 ]
Liu, Benyu [1 ,3 ]
Fan, Zusen [1 ]
机构
[1] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, CAS Key Lab Infect & Immun, Beijing 100101, Peoples R China
[2] Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Peoples R China
[3] Zhengzhou Univ, Acad Med Sci, Res Ctr Basic Med, Zhengzhou 450001, Peoples R China
来源
FUNDAMENTAL RESEARCH | 2023年 / 3卷 / 05期
基金
中国国家自然科学基金;
关键词
LncRNA; CircRNA; Cancer stem cells; Tumorigenesis; Niche; CELL-CYCLE PROGRESSION; CIRCULAR RNA; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; LUNG-CANCER; LNCRNA; APOPTOSIS; MYC; TRANSCRIPTION; GLIOBLASTOMA;
D O I
10.1016/j.fmre.2023.05.014
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumorigenesis is a complicated process in which numerous modulators are involved in different ways. Previous studies have focused primarily on tumor-associated protein-coding genes such as oncogenes and tumor suppressor genes, as well as their associated oncogenic pathways. However, noncoding RNAs (ncRNAs), rising stars in diverse physiological and pathological processes, have recently emerged as additional modulators in tumorigenesis. In this review, we focus on two typical kinds of ncRNAs: long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs). We describe the molecular patterns of ncRNAs and focus on the roles of ncRNAs in cancer stem cells (CSCs), tumor cells, and tumor environmental cells. CSCs are a small subset of tumor cells and are generally considered to be cells that initiate tumorigenesis, and dozens of ncRNAs have been defined as critical modulators in CSC maintenance and oncogenesis. Moreover, ncRNAs are widely involved in oncogenetic processes, including sustaining proliferation, resisting cell death, genome instability, metabolic disorders, immune escape and metas-tasis. We also discuss the potential applications of ncRNAs in tumor diagnosis and therapy. The progress in ncRNA research greatly improves our understanding of ncRNAs in oncogenesis and provides new potential targets for future tumor therapy.
引用
收藏
页码:692 / 706
页数:15
相关论文
共 50 条
  • [1] ROLE OF NONCODING RNAS IN TUMORIGENESIS
    Garen, Alan
    Song, Xu
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3288 - 3289
  • [2] Noncoding RNAs: Different roles in tumorigenesis
    Lin Mei
    Wu Jing
    Shan Ge
    CHINESE SCIENCE BULLETIN, 2012, 57 (09): : 959 - 965
  • [3] Noncoding RNAs:Different roles in tumorigenesis
    LIN MeiWU Jing SHAN Ge School of Life SciencesUniversity of Science and Technology of ChinaHefei China School of Life Science and TechnologyHuazhong University of Science and TechnologyWuhan China
    Chinese Science Bulletin, 2012, 57 (09) : 959 - 965
  • [4] Noncoding RNAs:Different roles in tumorigenesis
    LIN Mei1
    2 School of Life Science and Technology
    Science Bulletin, 2012, (09) : 959 - 965
  • [5] Role of human noncoding RNAs in the control of tumorigenesis
    Li, Ling
    Feng, Tingting
    Lian, Yingying
    Zhang, Guangfeng
    Garen, Alan
    Song, Xu
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (31) : 12956 - 12961
  • [6] Noncoding RNAs in Tumor Angiogenesis
    Khorshidi, Azam
    Dhaliwal, Preet
    Yang, Burton B.
    LONG AND SHORT NONCODING RNAS IN CANCER BIOLOGY, 2016, 927 : 217 - 241
  • [7] Long Noncoding RNAs: Emerging Biomarkers of Therapy Resistance and Tumor Progression
    Deshpande, Ravindra P.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [8] Long Noncoding RNAs: Emerging Biomarkers of Therapy Resistance and Tumor Progression
    Deshpande, Ravindra P.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [9] Influence of the interaction between long noncoding RNAs and hypoxia on tumorigenesis
    Dong, Jun
    Xu, Jiangbing
    Wang, Xiang
    Jin, Bilian
    TUMOR BIOLOGY, 2016, 37 (02) : 1379 - 1385
  • [10] Noncoding RNAs as sensors of tumor microenvironmental stress
    Lv, Yue
    Lv, Yinghao
    Wang, Zhen
    Yuan, Kefei
    Zeng, Yong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)